133 related articles for article (PubMed ID: 37285182)
1. The Positive and Negative Predictive Value of Targeted Diagnostic Botox Injection in Nerve Decompression Migraine Surgery.
ElHawary H; Kavanagh K; Janis JE
Plast Reconstr Surg; 2024 May; 153(5):1133-1140. PubMed ID: 37285182
[TBL] [Abstract][Full Text] [Related]
2. Clinical Effectiveness of Peripheral Nerve Blocks for Diagnosis of Migraine Trigger Points.
Rangwani SM; Hehr JC; Janis JE
Plast Reconstr Surg; 2021 Dec; 148(6):992e-1000e. PubMed ID: 34847126
[TBL] [Abstract][Full Text] [Related]
3. A comparison of outcome of surgical treatment of migraine headaches using a constellation of symptoms versus botulinum toxin type A to identify the trigger sites.
Liu MT; Armijo BS; Guyuron B
Plast Reconstr Surg; 2012 Feb; 129(2):413-419. PubMed ID: 21987048
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of migraine headaches.
Guyuron B; Tucker T; Davis J
Plast Reconstr Surg; 2002 Jun; 109(7):2183-9. PubMed ID: 12045534
[TBL] [Abstract][Full Text] [Related]
5. Confirmation of surgical decompression to relieve migraine headaches.
Poggi JT; Grizzell BE; Helmer SD
Plast Reconstr Surg; 2008 Jul; 122(1):115-122. PubMed ID: 18594393
[TBL] [Abstract][Full Text] [Related]
6. Five-year outcome of surgical treatment of migraine headaches.
Guyuron B; Kriegler JS; Davis J; Amini SB
Plast Reconstr Surg; 2011 Feb; 127(2):603-608. PubMed ID: 20966820
[TBL] [Abstract][Full Text] [Related]
7. Positive botulinum toxin type a response is a prognosticator for migraine surgery success.
Lee M; Monson MA; Liu MT; Reed D; Guyuron B
Plast Reconstr Surg; 2013 Apr; 131(4):751-757. PubMed ID: 23542247
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.
Binder WJ; Brin MF; Blitzer A; Schoenrock LD; Pogoda JM
Otolaryngol Head Neck Surg; 2000 Dec; 123(6):669-76. PubMed ID: 11112955
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin injection in the management of chronic migraine: the Saudi experience with a proposal for a new protocol.
Algahtani H; Shirah B; Sukkar G; Bukhari H; Meftah I; Alhazmi A; Alshareef A; Algethami A; Alshanqiti A; Andeejani M
Acta Neurol Belg; 2021 Dec; 121(6):1783-1787. PubMed ID: 33058053
[TBL] [Abstract][Full Text] [Related]
10. Validation of the peripheral trigger point theory of migraine headaches: single-surgeon experience using botulinum toxin and surgical decompression.
Janis JE; Dhanik A; Howard JH
Plast Reconstr Surg; 2011 Jul; 128(1):123-131. PubMed ID: 21701329
[TBL] [Abstract][Full Text] [Related]
11. Botox treatment for migraine and chronic daily headache in adolescents.
Chan VW; McCabe EJ; MacGregor DL
J Neurosci Nurs; 2009 Oct; 41(5):235-43. PubMed ID: 19835236
[TBL] [Abstract][Full Text] [Related]
12. The Use of Botulinum Toxin Type A in Medically Refractory Pediatric Patients With Chronic Daily Headaches and Its Impact on the Quality of Life.
Akbar A; Ford J; Tripathi S
J Child Neurol; 2024 Jan; 39(1-2):55-60. PubMed ID: 38351705
[No Abstract] [Full Text] [Related]
13. Targeted Peripheral Nerve-directed Onabotulinumtoxin A Injection for Effective Long-term Therapy for Migraine Headache.
Janis JE; Barker JC; Palettas M
Plast Reconstr Surg Glob Open; 2017 Mar; 5(3):e1270. PubMed ID: 28458982
[TBL] [Abstract][Full Text] [Related]
14. The Current Means for Detection of Migraine Headache Trigger Sites.
Guyuron B; Nahabet E; Khansa I; Reed D; Janis JE
Plast Reconstr Surg; 2015 Oct; 136(4):860-867. PubMed ID: 26397259
[TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled surgical trial of the treatment of migraine headaches.
Guyuron B; Reed D; Kriegler JS; Davis J; Pashmini N; Amini S
Plast Reconstr Surg; 2009 Aug; 124(2):461-468. PubMed ID: 19644260
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Role of Fat Injection in the Treatment of Recalcitrant Migraine Headaches.
Guyuron B; Pourtaheri N
Plast Reconstr Surg; 2019 Mar; 143(3):877-885. PubMed ID: 30817663
[TBL] [Abstract][Full Text] [Related]
17. [Botulinum toxin injections for chronic migraine in adolescents - an early therapeutic option in the transition from neuropaediatrics to neurology].
Bernhard MK; Bertsche A; Syrbe S; Weise S; Merkenschlager A
Fortschr Neurol Psychiatr; 2014 Jan; 82(1):39-42. PubMed ID: 24446117
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Long-Term, Targeted OnabotulinumtoxinA versus Peripheral Trigger Site Deactivation Surgery for the Treatment of Refractory Migraine Headaches.
Schoenbrunner AR; Khansa I; Janis JE
Plast Reconstr Surg; 2020 Feb; 145(2):401e-406e. PubMed ID: 31985655
[TBL] [Abstract][Full Text] [Related]
19. Trigger areas nerve decompression for refractory chronic migraine.
Chen G; You H; Juha H; Lou B; Zhong Y; Lian X; Peng Z; Xu T; Yuan L; Woralux P; Hugo AB; Jianliang C
Clin Neurol Neurosurg; 2021 Jul; 206():106699. PubMed ID: 34053808
[TBL] [Abstract][Full Text] [Related]
20. The use of onabotulinum toxin A (Botox(®)) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study.
Russo M; Manzoni GC; Taga A; Genovese A; Veronesi L; Pasquarella C; Sansebastiano GE; Torelli P
Neurol Sci; 2016 Jul; 37(7):1127-31. PubMed ID: 27048312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
